INVESTIGATION OF IMMUNOLOGICAL ADJUVANT ACTIVITIES OF PANAX GIENSENG SAPONINS IN MOUSE MODEL

Main Article Content

Khadija Gilani
Kamran Ajmal Khan
Maryam Mureed
Saba Nasir
Hina Ashraf

Keywords

.

Abstract

The development of effective vaccines hinges upon the inclusion of an appropriate immunopotentiator or adjuvant to enhance both cellular and humoral immune responses. Adjuvants are compounds designed to augment vaccine efficacy, and there exists an imminent need for the creation of novel and improved adjuvants. Saponins, classified as amphipathic glycosides, have garnered significant attention due to their multifaceted biological activities and their ability to stimulate immune responses when paired with antigens like ovalbumin. In this investigation, Panax ginseng roots were purchased from Hyolim Agriculture Farming in North Korea, for saponin extraction. Methanol and n-butanol extraction protocol were employed for saponin extraction, and their profiles were meticulously characterized through Flash Chromatography (FC), TLC and HPLC. Two primary fractions, designated as PS-1 (Panax ginseng-1) and PS-2 (Panax ginseng-2), were isolated and subjected to evaluation as adjuvants in a mouse model, alongside ovalbumin. Over the course of 20 days, four groups of mouse were immunized with varying doses of PS-1 and PS-2, encompassing fractions such as PS-1±40, PS-1±60, PS-2±80, and PS-2±100. The adjuvant activity was subsequently compared with QuilA saponin (QuilA±100), while a sixth group of mouse immunized ovalbumin alone. Immunization responses were assessed at primary and secondary stages on the 10th and 20th days, respectively, by quantifying IgG, IgG4 subclass antibodies, and Interleukin-6 (IL-6) concentrations through ELISA. The findings revealed that increasing doses of Panax ginseng saponins led to heightened levels of IgG and IgG4 subclass antibodies in mouse serum, concurrently with the induction of IL-6 responses discerned from spleen cell cultures. Remarkably, the PS-2±100 saponin dose exhibited a substantial upsurge, elevating IgG antibody concentration by 96.26%, IgG subclass antibody concentration by 85.19%, and triggering a notable increase in IL-6 levels (246.67 pg/l on the 20th day), as evidenced by a 0.51 optical density (OD) value post-immunization. In conclusion, Panax ginseng saponins, particularly the PS-2±100 fraction, demonstrate potent adjuvant capabilities, significantly enhancing both humoral and cellular immune responses when administered alongside ovalbumin. This research contributes valuable insights into the exploration of natural saponins as promising vaccine adjuvants, highlighting their substantial immunostimulatory potential and their prospective role in vaccine formulations.

Abstract 214 | pdf Downloads 110

References

1. Shah, Ruchi R, Kimberly J. Hassett, and Luis A. Brito. "Overview of vaccine adjuvants: Introduction, history, and current status." Vaccine Adjuvants: Methods and Protocols, vol. 1, no. 13, (2017).
2. Chen, Chun Tao, Zhi Jun Wang, Moses Sing Sum Chow, and Christopher Wai Kei Lam. "Herb-herb combination for therapeutic enhancement and advancement: theory, practice, and future perspectives." Molecules, vol. 18, no. 5, pp 5125-5141, 2013.
3. Kiefer, David S, and Traci Pantuso. "Panax ginseng." American family physician, vol. 68, no. 8, pp. 1539-1542, (2003).
4. Cheng, Yong, Li.hong Shen, and Jun.tian Zhang. "Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action." ACTA pharmacologica sinica, vol. 26, no. 2, pp. 143-149, 2015.
5. Chan, L. Y., P. Y. Chiu, and T. K. Lau. "An in‐vitro study of ginsenoside Rb1‐induced teratogenicity using a whole rat embryo culture model." Human Reproduction, vol. 18, no. 10, pp. 2166-2168, 2003.
6. El Ashmaoui, H. M., and S. M. Girgis. "Evaluation of the potential mutagenic effects of ginseng on maternally treated post-implanted mouse foetuses." The Egyptian Journal of Hospital Medicine, vol. 13, no. 1, pp. 57-65, (2003).
7. Shi, Ze.Yu, Jin.Zhang Zeng, and Alice Sze Tsai Wong. "Chemical structures and pharmacological profiles of ginseng saponins." Molecules, vol. 24, no. 13, pp. 2443, (2019).
8. Shin, Dong Jin, Myung Ha Yoon, Hyung Gon Lee, Woong Mo Kim, Byung Yun Park, Yeo Ok Kim, Lan Ji Huang, and Jin Hua Cui. "The effect of treatment with intrathecal ginsenosides in a rat model of postoperative pain." The Korean Journal of Pain, vol. 20, no. 2, pp. 100-105, 2007.
9. Lü, Jian.Ming, Jun Jiang, Md Saha Jamaluddin, Zhengdong Liang, Qizhi Yao, and Changyi Chen. "Ginsenoside Rb1 blocks ritonavir-induced oxidative stress and eNOS downregulation through activation of estrogen receptor-beta and upregulation of SOD in human endothelial cells." International Journal of Molecular Sciences, vol. 20, no. 2, pp. 294, 2019.
10. Shin, Kyung.Chul, and Deok.Kun Oh. "Classification of glycosidases that hydrolyze the specific positions and types of sugar moieties in ginsenosides." Critical reviews in biotechnology, vol. 36, no. 6, pp. 1036-1049, 2016.
11. Wan, Jin.Yi, Chong.Zhi Wang, Zhi Liu, Qi.Hui Zhang, Mark W. Musch, Marc Bissonnette, Eugene B. Chang, Ping Li, Lian.Wen Qi, and Chun.Su Yuan. "Determination of American ginseng saponins and their metabolites in human plasma, urine and feces samples by liquid chromatography coupled with quadrupole time-of-flight mass spectrometry." Journal of Chromatography B, no. 1015, pp. 62-73, 2016.
12. Ben.Hur, Ehud, and Stephen Fulder. "Effect of Panax ginseng saponins and Eleutherococcus senticosus on survival of cultured mammalian cells after ionizing radiation." The American Journal of Chinese Medicine, vol. 9, no. 01, pp. 48-56, 1981.
13. Attele, Anoja S., Ji An Wu, and Chun.Su Yuan. "Ginseng pharmacology: multiple constituents and multiple actions." Biochemical pharmacology, vol. 58, no. 11, pp. 1685-1693, 1999.
14. Yuan, Chun.Su, Chong.Zhi Wang, Sheila M. Wicks, and Lian.Wen Qi. "Chemical and pharmacological studies of saponins with a focus on American ginseng." Journal of ginseng research, vol. 34, no. 3, pp. 160, 2010.
15. Welkos, Susan, and Alison O'Brien. "[2] Determination of median lethal and infectious doses in animal model systems." Methods in enzymology, vol. 235, pp. 29-39, 1994.
16. Bladt, Sabine. Plant Drug Analysis: A thin layer chromatography atlas. Springer Science & Business Media, 2009.
17. Stavrianidi, Andrey, Igor Rodin, Arkady Braun, Elena Stekolshchikova, and Oleg Shpigun. "Single.run HPLC/ESI‐LITMS profiling of ginsenosides in plant extracts and ginseng based products." Biomedical Chromatography, vol. 29, no. 6, pp. 853-859, 2015.
18. van Setten, Dirk C., and Gerrit van de Werken. "Molecular structures of saponins from Quillaja saponaria Molina." Saponins used in traditional and modern medicine, pp. 185-193, 1996.
19. Liu, Xiaojie, Samantha Ahlgren, Henrie AAJ Korthout, Luis F. Salomé.Abarca, Lina M. Bayona, Robert Verpoorte, and Young Hae Choi. "Broad range chemical profiling of natural deep eutectic solvent extracts using a high performance thin layer chromatography–based method." Journal of Chromatography A, vol. 1532, pp.198-207, 2018.
20. Eppstein, Deborah A., Noelene E. Byars, and Anthony C. Allison. "New adjuvants for vaccines containing purified protein antigens." Advanced Drug Delivery Reviews, vol. 4, no. 2, pp. 233-253,1989.
21. Hwang, Su.Hyun, Myoung.Sook Shin, Taek Joon Yoon, and Kwang.Soon Shin. "Immunoadjuvant activity in mice of polysaccharides isolated from the leaves of Panax ginseng CA Meyer." International journal of biological macromolecules, vol. 107, pp. 2695-2700, 2018.
22. Qiu, Tianxin, Pengfei Gu, Adelijiang Wusiman, Haiyu Ni, Shuwen Xu, Yue Zhang, Tianyu Zhu et al. "Immunoenhancement effects of chitosan-modified ginseng stem-leaf saponins-encapsulated cubosomes as an ajuvant." Colloids and Surfaces B: Biointerfaces, vol. 204, pp. 111799, 2021.
23. Zhuo, Xunhui, Hongchao Sun, Suhua Wang, Xiaolu Guo, Haojie Ding, Yi Yang, Ying Shan, and Aifang Du. "Ginseng stem-and-leaf saponin (GSLS)-Enhanced protective immune responses induced by Toxoplasma gondii heat shocked protein 70 (HSP70) against toxoplasmosis in mice." Journal of Parasitology, vol. 103, no. 1, pp. 111-117, 2017.
24. Wang, Yong, Xuemei Cui, Lijia Yuan, Babar Maqbool, Wei Xu, Shanshan He, Ran Guan, and Songhua Hu. "A solution with ginseng saponins and selenium as vaccine diluent to increase Th1/Th2 immune responses in mice." Journal of Immunology Research, vol. 2020, pp. 1-13, 2020.
25. Mosmann, T.R., Schumacher, J.H., Street, N.F., Budd, R., O'garra, A., Fong, T.A.T., Bind, M.W., Moore, K.W.M., Sher, A. and Fiorentino, D.F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunological reviews, vol. 123, no. 1, pp.209-229, 1991.
26. Huang, Yiqun, Yong Zou, Luhui Lin, and Ruiji Zheng. "Ginsenoside Rg1 activates dendritic cells and acts as a vaccine adjuvant inducing protective cellular responses against lymphomas." DNA and Cell Biology, vol. 36, no. 12, pp. 1168-1177, 2017.
27. Lee, Yun.Kyung, Kyung.Hoon Choi, Hae.Soo Kwak, and Yoon Hyuk Chang. "The preventive effects of nanopowdered red ginseng on collagen-induced arthritic mice." International Journal of Food Sciences and Nutrition, vol. 69, no. 3, pp. 308-317, 2018.
28. Ratan, Zubair Ahmed, Mohammad Faisal Haidere, Yo Han Hong, Sang Hee Park, Jeong.Oog Lee, Jongsung Lee, and Jae Youl Cho. "Pharmacological potential of ginseng and its major component ginsenosides." Journal of ginseng research, vol. 45, no. 2, pp. 199-210, 2021.
29. Wang, Lei, Xiankui Li, Yi Min Song, Bin Wang, Fu Rui Zhang, Rui Yang, Hua.Qi Wang, and Guo.Jun Zhang. "Ginsenoside Rg3 sensitizes human non small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway." Molecular Medicine Reports, vol. 12, no. 1, pp. 609-614, 2015.